Uncategorized
Five FDA ophthalmology actions in August
The FDA moved forward on multiple ophthalmology-related products in the month of August. Here are the top five advancements as reported on Healio.com/OSN: 1. Retinitis pigmentosa gene therapy gets orphan drug designation.